American college of medical genetics and genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss

Genetics in Medicine

Volumn 16, Issue 4, 2014, Pages 347-355

  Alford, Raye L ^a   Arnos, Kathleen S ^b   Fox, Michelle ^c   Lin, Jerry W ^a   Palmer, Christina G ^c   Pandya, Arti ^d   Rehm, Heidi L ^e   Robin, Nathaniel H ^f   Scott, Daryl A ^a   Yoshinaga Itano, Christine ^g  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b GALLAUDET UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Deaf; deaf; genetic counseling; genetic testing; genetics evaluation; guideline; hard of hearing; hearing loss

Indexed keywords

ARTICLE; AUDIOMETRY; CLINICAL EVALUATION; CLINICAL FEATURE; CONGENITAL RUBELLA SYNDROME; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HEALTH SERVICE; HEARING IMPAIRMENT; HUMAN; MEDICAL GENETICS; PATIENT EDUCATION; PRACTICE GUIDELINE; RECURRENT DISEASE; DOCTOR PATIENT RELATION; GENETICS; HEALTH CARE DELIVERY; HEARING LOSS; PATHOLOGY; UNITED STATES;

DELIVERY OF HEALTH CARE; GENETIC COUNSELING; GENETIC TESTING; HEARING LOSS; HUMANS; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84898448235     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.2     Document Type: Article

References (114)

1. Finitzo T, Albright K, O'Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics 1998;102:1452-1460.
2. Yoshinaga-Itano C, Coulter D, Thomson V. Developmental outcomes of children with hearing loss born in Colorado hospitals with and without universal newborn hearing screening programs. Semin Neonatol 2001;6:521-529.
3. American Academy of Audiology Childhood Hearing Screening Guidelines. American Academy of Audiology [serial online] 2012; American Academy of Audiology. http://www.cdc.gov/ncbddd/hearingloss/documents/AAA- Childhood%20Hearing%20Guidelines-2011.pdf. Accessed 12 June 2012.
4. Harlor AD Jr, Bower C; Committee on Practice and Ambulatory Medicine; Section on Otolaryngology-Head and Neck Surgery. Hearing assessment in infants and children: recommendations beyond neonatal screening. Pediatrics 2009;124:1252-1263.
5. Marazita ML, Ploughman LM, Rawlings B, Remington E, Arnos KS, Nance WE. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993;46:486-491.
6. Mitchell RE, Karchmer MA. Chasing the mythical ten percent: parental hearing status of deaf and hard of hearing students in the United States. Sign Lang Studies 2004;4:138-163.
7. Pandya A, Arnos KS, Xia XJ, et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med 2003;5:295-303.
8. National Institute on Deafness and Other Communication Disorders (NIDCD): Presbycusis Health Statistics. National Institute on Deafness and Other Communication Disorders [serial online] 2011; http://www.nidcd.nih.gov/health/ hearing/presbycusis.htm. Accessed 12 June 2012.
9. Carlsson PI, Van Laer L, Borg E, et al. The influence of genetic variation in oxidative stress genes on human noise susceptibility. Hear Res 2005;202:87-96.
10. Friedman RA, Van Laer L, Huentelman MJ, et al. GRM7 variants confer susceptibility to age-related hearing impairment. Hum Mol Genet 2009;18:785-796.
11. Op de Beeck K, Schacht J, Van CG. Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell. Hear Res 2011;281:18-27.
12. Unal M, Tamer L, Dogruer ZN, Yildirim H, Vayisoglu Y, Camdeviren H. N-acetyltransferase 2 gene polymorphism and presbycusis. Laryngoscope 2005;115:2238-2241.
13. Van Eyken E, Van Camp G, Van Laer L. The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol Neurootol 2007;12:345-358.
14. Van Laer L, Van Eyken E, Fransen E, et al. The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment. Hum Mol Genet 2008;17:159-169.
15. Kochhar A, Hildebrand MS, Smith RJ. Clinical aspects of hereditary hearing loss. Genet Med 2007;9:393-408.
16. Pandya A, Arnos KS. Genetic evaluation and counseling in the context of early hearing detection and intervention. Semin Hear 2006;27:205-212.
17. Robin NH, Prucka SK, Woolley AL, Smith RJ. The use of genetic testing in the evaluation of hearing impairment in a child. Curr Opin Pediatr 2005;17: 709-712.
18. American Speech-Language-Hearing Assocation: Degree of Hearing Loss. American Speech-Language-Hearing Association (AHSA) [serial online] 2012; American Speech-Language-Hearing Association (AHSA). http://www.asha.org/public/ hearing/Degree-of-Hearing-Loss/. Accessed 12 June 2012.
19. Pagon RA, Adam MP, Bird TD, et al., (eds). GeneReviews [Internet] University of Washington: Seattle, WA, 1993-2011. http://www.ncbi.nlm.nih.gov/ books/NBK1116. Accessed 7 February 2014.
20. Hereditary Hearing Loss and Its Syndromes, 3rd edn. Toriello HV, Smith S (eds). Oxford University Press: New York, NY, 2013.
21. Van Camp G, Smith RJ. Hereditary Hearing Loss Homepage. Hereditary Hearing Loss Homepage [serial online] 2011; http://hereditaryhearingloss.org. Accessed 12 June 2012.
22. Kimberling WJ, Hildebrand MS, Shearer AE, et al. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med 2010;12:512-516.
23. Park HJ, Shaukat S, Liu XZ, et al. Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 2003;40:242-248.
24. Smith RJH. Branchiootorenal Spectrum Disorders. GeneReviews [serial online] 1993; PMID:20301554. University of Washington, Seattle, WA. http://www.ncbi.nlm.nih.gov/books/NBK1380. Accessed 26 November 2013.
25. Yuan Y, Guo W, Tang J, et al. Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China. PLoS ONE 2012;7:e49984.
26. Schultz JM. Waardenburg syndrome. Semin Hear 2006;27:171-181.
27. Madeo AC, Pryor SP, Brewer C et al. Pendred syndrome. Semin Hear 2006;27:160-170.
28. Bamiou DE, Savy L, O'Mahoney C, Phelps P, Sirimanna T. Unilateral sensorineural hearing loss and its aetiology in childhood: the contribution of computerised tomography in aetiological diagnosis and management. Int J Pediatr Otorhinolaryngol 1999;51:91-99.
29. Dodson KM, Georgolios A, Barr N, et al. Etiology of unilateral hearing loss in a national hereditary deafness repository. Am J Otolaryngol 2012;33:590-594.
30. Li Z, Li R, Chen J, et al. Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss. Hum Genet 2005;117:9-15.
31. Pandya A, Xia X, Radnaabazar J, et al. Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet 1997;34:169-172.
32. Abe S, Usami S, Shinkawa H, Kelley PM, Kimberling WJ. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 2000;37:41-43.
33. Denoyelle F, Marlin S, Weil D, et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 1999;353:1298-1303.
34. Estivill X, Fortina P, Surrey S, et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998;351:394-398.
35. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary nonsyndromic sensorineural deafness. Nature 1997;387:80-83.
36. Kenneson A, Van Naarden Braun K, Boyle C. GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genet Med 2002;4:258-274.
37. Kudo T, Ikeda K, Kure S, et al. Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet 2000;90:141-145.
38. RamShankar M, Girirajan S, Dagan O, et al. Contribution of connexin26 (GJB2) mutations and founder effect to non-syndromic hearing loss in India. J Med Genet 2003;40:e68.
39. Chan DK, Schrijver I, Chang KW. Connexin-26-associated deafness: phenotypic variability and progression of hearing loss. Genet Med 2010;12:174-181.
40. Kenna MA, Feldman HA, Neault MW, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg 2010;136:81-87.
41. Norris VW, Arnos KS, Hanks WD, Xia X, Nance WE, Pandya A. Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness. Ear Hear 2006;27:732-741.
42. Snoeckx RL, Huygen PL, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945-957.
43. del Castillo FJ, Rodríguez-Ballesteros M, Alvarez A, et al. A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 nonsyndromic hearing impairment. J Med Genet 2005;42:588-594.
44. del Castillo I, Villamar M, Moreno-Pelayo MA, et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002;346:243-249.
45. Del Castillo I, Moreno-Pelayo MA, Del Castillo FJ, et al. Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study. Am J Hum Genet 2003;73:1452-1458.
46. Feldmann D, Denoyelle F, Chauvin P, et al. Large deletion of the GJB6 gene in deaf patients heterozygous for the GJB2 gene mutation: genotypic and phenotypic analysis. Am J Med Genet A 2004;127A:263-267.
47. Fitzgerald T, Duva S, Ostrer H, et al. The frequency of GJB2 and GJB6 mutations in the New York State newborn population: feasibility of genetic screening for hearing defects. Clin Genet 2004;65:338-342.
48. Palmer CG, Martinez A, Fox M, et al. A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants. Am J Med Genet A 2009;149A:1169-1182.
49. de Zwart-Storm EA, van Geel M, Veysey E, et al. A novel missense mutation in GJB2, p. Tyr65His, causes severe Vohwinkel syndrome. Br J Dermatol 2011;164:197-199.
50. Iossa S, Marciano E, Franzé A. GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss. Curr Genomics 2011;12:475-785.
51. Richard G, Rouan F, Willoughby CE, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis- deafness syndrome. Am J Hum Genet 2002;70:1341-1348.
52. Pandya A. Nonsyndromic Hearing Loss and Deafness, Mitochondrial. 22 October 2004 [updated 21 April 2011]. In: Pagon RA, Adam MP, Bird TD, et al. (eds). Gene Reviews [Internet] University of Washington: Seattle, WA, 1993-2014. http://www.ncbi.nlm.nih.gov/books/NBK1422. Accessed 7 February 2014.
53. Estivill X, Govea N, Barceló E, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet 1998;62:27-35.
54. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289-294.
55. Rahman S, Ecob R, Costello H, et al. Hearing in 44-45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study. BMJ Open 2012;2:e000411.
56. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991;630:16-31.
57. Davis RR, Kozel P, Erway LC. Genetic influences in individual susceptibility to noise: a review. Noise Health 2003;5:19-28.
58. Tak S, Davis RR, Calvert GM. Exposure to hazardous workplace noise and use of hearing protection devices among US workers-NHANES, 1999-2004. Am J Ind Med 2009;52:358-371.
59. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008;41:57-62.
60. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-363.
61. Yamamoto AY, Mussi-Pinhata MM, Isaac Mde L, et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J 2011;30:1043-1046.
62. Morton CC, Nance WE. Newborn hearing screening-a silent revolution. N Engl J Med 2006;354:2151-2164.
63. Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle JP. Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States. J Infect Dis 2011;204(suppl 2):S593-S597.
64. Plotkin SA. The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis 2006;43(suppl 3):S164-S168.
65. Rubella: Fact sheet No. 367. World Health Organization [serial online] 2012;http://www.who.int/mediacentre/factsheets/fs367/en/. Accessed 29 November 2013.
66. Stein LK, Boyer KM. Progress in the prevention of hearing loss in infants. Ear Hear 1994;15:116-125.
67. Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics 2005;115:1519-1528.
68. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed 2000;82:F141-F144.
69. Robertson CM, Howarth TM, Bork DL, Dinu IA. Permanent bilateral sensory and neural hearing loss of children after neonatal intensive care because of extreme prematurity: a thirty-year study. Pediatrics 2009;123:e797-e807.
70. Boudreault P, Baldwin EE, Fox M, et al. Deaf adults' reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study. J Deaf Stud Deaf Educ 2010;15:209-227.
71. Brunger JW, Murray GS, O'Riordan M, Matthews AL, Smith RJ, Robin NH. Parental attitudes toward genetic testing for pediatric deafness. Am J Hum Genet 2000;67:1621-1625.
72. Burton SK, Withrow K, Arnos KS, Kalfoglou AL, Pandya A. A focus group study of consumer attitudes toward genetic testing and newborn screening for deafness. Genet Med 2006;8:779-783.
73. Palmer CG, Martinez A, Fox M, Sininger Y, Grody WW, Schimmenti LA. Ethnic differences in parental perceptions of genetic testing for deaf infants. J Genet Couns 2008;17:129-138.
74. Palmer CG, Boudreault P, Baldwin EE, et al. Deaf genetic testing and psychological well-being in deaf adults. J Genet Couns 2013;22:492-507.
75. Robin NH. Medical Genetics: Its Application to Speech, Hearing, and Craniofacial Disorders. Plural Publishing: San Diego, California, 2008.
76. Robin NH. It does matter: the importance of making the diagnosis of a genetic syndrome. Curr Opin Pediatr 2006;18:595-597.
77. Withrow KA, Burton S, Arnos KS, Kalfoglou A, Pandya A. Consumer motivations for pursuing genetic testing and their preferences for the provision of genetic services for hearing loss. J Genet Couns 2008;17:252-260.
78. Withrow KA, Tracy KA, Burton SK, et al. Impact of genetic advances and testing for hearing loss: results from a national consumer survey. Am J Med Genet A 2009;149A:1159-1168.
79. Withrow KA, Tracy KA, Burton SK, et al. Provision of genetic services for hearing loss: results from a national survey and comparison to insights obtained from previous focus group discussions. J Genet Couns 2009;18:618-621.
80. Middleton A, Palmer CGS. Clients who are D/deaf or hard of hearing. In: Wiggins J, Middleton A (eds). Getting the Message Across: Communication with Diverse Populations in Clinical Genetics. Oxford University Press: Oxford, UK, 2012.
81. Lane H. Ethnicity, ethics, and the deaf-world. J Deaf Stud Deaf Educ 2005;10:291-310.
82. Padden CA, Humphries TL. Deaf in America: Voices from a Culture. Harvard University Press: Cambridge, MA, 1988.
83. Martinez A, Linden J, Schimmenti LA, Palmer CG. Attitudes of the broader hearing, deaf, and hard-of-hearing community toward genetic testing for deafness. Genet Med 2003;5:106-112.
84. Middleton A, Hewison J, Mueller RF. Attitudes of deaf adults toward genetic testing for hereditary deafness. Am J Hum Genet 1998;63:1175-1180.
85. Sankar P, Cho MK, Wolpe PR, Schairer C. What is in a cause? Exploring the relationship between genetic cause and felt stigma. Genet Med 2006; 8:33-42.
86. Baldwin EE, Boudreault P, Fox M, Sinsheimer JS, Palmer CG. Effect of pre-test genetic counseling for deaf adults on knowledge of genetic testing. J Genet Couns 2012;21:256-272.
87. Middleton A, Emery SD, Turner GH. Views, knowledge, and beliefs about genetics and genetic counseling among deaf people. Sign Lang Studies 2010;10:170-196.
88. Arnos KS, Cunningham M, Israel J, Marazita ML. Innovative approach to genetic counseling services for the deaf population. Am J Med Genet 1992;44: 345-351.
89. Israel J, Cunningham M, Thumann H, Arnos KS. Genetic counseling for deaf adults: Communication/language and cultural considerations. J Genet Couns 1992;1:135-153.
90. Bonnet C, Grati M, Marlin S, et al. Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. Orphanet J Rare Dis 2011;6:21.
91. Usami S, Nishio SY, Nagano M, Abe S, Yamaguchi T; Deafness Gene Study Consortium. Simultaneous screening of multiple mutations by invader assay improves molecular diagnosis of hereditary hearing loss: a multicenter study. PLoS ONE 2012;7:e31276.
92. Brown KK, Rehm HL. Molecular diagnosis of hearing loss. Curr Protoc Hum Genet 2012;72:9.16.1-9.16.16.
93. Brownstein Z, Friedman LM, Shahin H, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 2011;12:R89.
94. Shearer AE, DeLuca AP, Hildebrand MS, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA 2010;107:21104-21109.
95. Shearer AE, Hildebrand MS, Sloan CM, Smith RJ. Deafness in the genomics era. Hear Res 2011;282:1-9.
96. Sirmaci A, Edwards YJ, Akay H, Tekin M. Challenges in whole exome sequencing: an example from hereditary deafness. PLoS ONE 2012; 7:e32000.
97. GeneTests: Medical Genetics Information Resource (database online). University of Washington, Seattle, WA, 1993-2011 [serial online] 2012. http://www.genetests.org. Accessed 30 June 2011.
98. GTR: Genetic Testing Registry. National Center for Biotechnology Information, US National Library of Medicine [serial online] 2012;http://www.ncbi.nlm.nih.gov/gtr/. Accessed 25 September 2012.
99. Rehm HL, Bale SJ, Bayrak-Toydemir P, et al.; Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733-747.
100. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574.
101. Boppana SB, Ross SA, Shimamura M, et al.; National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerasechain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011;364:2111-2118.
102. Lombardi G, Garofoli F, Stronati M. Congenital cytomegalovirus infection: treatment, sequelae and follow-up. J Matern Fetal Neonatal Med 2010;23(suppl 3):45-48.
103. Rosenthal LS, Fowler KB, Boppana SB, et al. Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal followup of children with congenital infection. Pediatr Infect Dis J 2009;28: 515-520.
104. Shin JJ, Keamy DG Jr, Steinberg EA. Medical and surgical interventions for hearing loss associated with congenital cytomegalovirus: a systematic review. Otolaryngol Head Neck Surg 2011;144:662-675.
105. Yamamoto AY, Mussi-Pinhata MM, Marin LJ, Brito RM, Oliveira PF, Coelho TB. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol 2006; 36:228-230.
106. Cohen M, Phillips JA 3rd. Genetic approach to evaluation of hearing loss. Otolaryngol Clin North Am 2012;45:25-39.
107. Reardon W, OMahoney CF, Trembath R, Jan H, Phelps PD. Enlarged vestibular aqueduct: a radiological marker of pendred syndrome, and mutation of the PDS gene. QJM 2000;93:99-104.
108. Lai R, Hu P, Zhu F, et al. Genetic diagnosis and cochlear implantation for patients with nonsyndromic hearing loss and enlarged vestibular aqueduct. J Laryngol Otol 2012;126:349-355.
109. Lin JW, Chowdhury N, Mody A, et al. Comprehensive diagnostic battery for evaluating sensorineural hearing loss in children. Otol Neurotol 2011;32:259-264.
110. Madden C, Halsted M, Meinzen-Derr J, et al. The influence of mutations in the SLC26A4 gene on the temporal bone in a population with enlarged vestibular aqueduct. Arch Otolaryngol Head Neck Surg 2007;133:162-168.
111. Chiang CE. Congenital and acquired long QT syndrome. Current concepts and management. Cardiol Rev 2004;12:222-234.
112. Tranebjaerg L, Samson RA, Green GE. Jervell and Lange-Nielsen Syndrome. Gene Reviews [serial online] 2010; PMID:20301579. University of Washington, Seattle, WA. http://www.ncbi.nlm.nih.gov/books/NBK1405. Accessed 15 June 2012.
113. Dyer JJ, Strasnick B, Jacobson JT. Teratogenic hearing loss: a clinical perspective. Am J Otol 1998;19:671-678.
114. Takemori S, Tanaka Y, Suzuki JI. Thalidomide anomalies of the ear. Arch Otolaryngol 1976;102:425-427.